Pencil maker DOMS Industries Ltd delivered robust financial results for the fourth quarter, with consolidated net profit rising 17.2% year-on-year to ₹56.7 crore compared with ₹48.4 crore in the corresponding quarter last year, as reported by CNBC TV18. Revenue increased 18.7% year-on-year to ₹604 crore from ₹509 crore in the same period last year. EBITDA rose 14.4% year-on-year to ₹101 crore, compared with ₹88.3 crore a year earlier, though EBITDA margin reduced to 16.7% from 17.4% in the corresponding quarter last year. The slight compression in EBITDA margins, a trend observed in previous fourth quarters, raises questions about operational efficiency amid strong top-line growth.
The board recommended a final dividend of ₹3.65 per equity share of face value ₹10 each for the financial year ended March 31, 2026, subject to shareholder approval at the ensuing annual general meeting, according to CNBC TV18. This dividend declaration reflects the company's strong cash generation capabilities and commitment to returning value to shareholders, reinforcing a commitment to consistent dividends that investors value.
The company approved the re-appointment of key leadership positions, subject to shareholder approval. Santosh Raveshia is proposed to be re-appointed as managing director for a five-year term from January 1, 2027, to December 31, 2031, as reported by CNBC TV18. Sanjay Rajani is proposed to be re-appointed as whole-time director for the same five-year period. Both appointments are part of the company's succession planning and maintain continuity in leadership, a factor often favored by institutional investors seeking stability.
Shares of DOMS Industries closed at ₹2,277 on May 18, 2026, reflecting a modest gain of 0.58%, according to CNBC TV18. The company trades at a premium valuation with its P/E ratio hovering around 60-64 times earnings, significantly higher than peers like Flair Writing Industries (P/E 29.44) and Kokuyo Camlin (P/E 37.56). This premium valuation suggests investors anticipate robust future growth, with analysts maintaining a 'Buy' consensus and average price target of ₹2,858.91, implying approximately 26% upside potential. The company's 5-year CAGR of 35.2% in earnings demonstrates strong historical performance, though recent Q4 EBITDA margin contraction from 18.8% in Q4 FY24 and 17.3% in Q4 FY25 presents challenges for maintaining premium valuations.
